Clinical Trial Update: REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID [NA]

View source ↗

Summary

A completed randomized controlled trial evaluating oxaloacetate for fatigue in long COVID (post-COVID-19 syndrome).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Oxaloacetate (oxaloacetate)

Snippet

Sponsor: Terra Biological LLC | Conditions: Post-COVID-19 Syndrome, Fatigue Syndrome, Chronic | NA | Status: COMPLETED